Gelesis Holdings (Gelesis Holdings) Equity-to-Asset : -0.33 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Gelesis Holdings Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Gelesis Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $-31.53 Mil. Gelesis Holdings's Total Assets for the quarter that ended in Jun. 2023 was $95.88 Mil. Therefore, Gelesis Holdings's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was -0.33.

The historical rank and industry rank for Gelesis Holdings's Equity-to-Asset or its related term are showing as below:

GLSWQ' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.26 Med: -0.24 Max: 0.07
Current: -0.33

During the past 2 years, the highest Equity to Asset Ratio of Gelesis Holdings was 0.07. The lowest was -2.26. And the median was -0.24.

GLSWQ's Equity-to-Asset is not ranked
in the Biotechnology industry.
Industry Median: 0.67 vs GLSWQ: -0.33

Gelesis Holdings Equity-to-Asset Historical Data

The historical data trend for Gelesis Holdings's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gelesis Holdings Equity-to-Asset Chart

Gelesis Holdings Annual Data

Trend

Dec21

Dec22

Equity-to-Asset

-2.26

-0.24

Gelesis Holdings Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Equity-to-Asset	Get a 7-Day Free Trial					0.04	-0.03	-0.24	-0.27	-0.33

Competitive Comparison of Gelesis Holdings's Equity-to-Asset

For the Biotechnology subindustry, Gelesis Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelesis Holdings's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's Equity-to-Asset falls into.

Gelesis Holdings Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Gelesis Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	-25.056	/	103.324
	=	-0.24

Gelesis Holdings's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	-31.53	/	95.875
	=	-0.33

Gelesis Holdings (OTCPK:GLSWQ) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Gelesis Holdings Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Gelesis Holdings's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Gelesis Holdings (Gelesis Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gelesis Holdings Inc (OTCPK:GLSWQ) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

501 Boylston Street, Suite 6102, Boston, MA, USA, 02116

Website

https://www.gelesis.com

Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.